Landmark Study Reveals Treatment Impact

Researchers at the Karolinska Institute in Sweden conducted the largest-ever multinational study examining how attention development status affects cardiovascular medication adherence. The study followed over 12.1 million adults across seven countries who began blood pressure treatment between 2010 and 2020.

The findings paint a clear picture: adults with attention development differences showed a 14% higher rate of discontinuing blood pressure medication over five years compared to those without such differences. At one year, they had 45% higher odds of poor adherence, widening to 64% higher odds at five years.